Literature DB >> 29456852

Xanthogranulomatous pituitary adenoma: A case report and literature review.

Guihong Li1, Chaochao Zhang1, Yuxue Sun1, Qingchun Mu2, Haiyan Huang1.   

Abstract

Xanthogranuloma, also referred to as cholesterol granuloma or xanthogranulomatous reaction, is a granulomatous lesion that is infrequently found in the sellar and parasellar regions. Xanthogranulomatous pituitary adenoma is relatively rare and, thus, the etiology, diagnosis, management and prognosis of this condition remain incompletely understood. We herein report the case of a 56-year-old female patient who presented to our institution with intermittent headache, vomiting and distending pain in the bilateral orbital regions. Brain magnetic resonance imaging revealed a sellar mass with a heterogeneous signal. The mass was subtotally resected, and histopathological examination confirmed the diagnosis of xanthogranulomatous pituitary adenoma. Although the patient's symptoms were relieved following surgical treatment, intractable hyponatremia and diabetes insipidus developed and she received hormone replacement therapy. At the last follow-up (November 2016), the patient remained recurrence-free. A total of 14 cases of pituitary adenoma with concomitant xanthogranuloma were identified in the literature, and the clinical and radiological manifestations are discussed. Sellar xanthogranuloma is usually associated with craniopharyngioma or Rathke's cleft cyst; however, it may also occur in isolation. Xanthogranulomatous pituitary adenomas are infrequent, making their diagnosis challenging. Surgical resection is the preferred treatment, and attention should be paid to postoperative hypopituitarism and development of diabetes insipidus.

Entities:  

Keywords:  diabetes insipidus; pituitary adenoma; sellar region; xanthogranuloma

Year:  2018        PMID: 29456852      PMCID: PMC5795491          DOI: 10.3892/mco.2018.1547

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  20 in total

1.  Neurosurgical biopsy as the initial diagnosis of xanthogranuloma of the Erdheim-Chester disease variety of the infundibulum and optic apparatus: letter to the editor.

Authors:  Adib A Abla; David A Wilson; Jennifer M Eschbacher; Robert F Spetzler
Journal:  Acta Neurochir (Wien)       Date:  2010-01-05       Impact factor: 2.216

2.  [Cholesterol granuloma at the sella region: a new method of the differential diagnosis of craniopharyngioma].

Authors:  I Vajtai; Z Kopniczky; Z Buza; J Kovács; Z Kovács; Z Varga; M Bodosi; W Paulus
Journal:  Orv Hetil       Date:  2001-03-04       Impact factor: 0.540

3.  Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma.

Authors:  W Paulus; J Honegger; K Keyvani; R Fahlbusch
Journal:  Acta Neuropathol       Date:  1999-04       Impact factor: 17.088

4.  Endocrinological and MRI features of pituitary adenomas with marked xanthogranulomatous reaction.

Authors:  Hiroshi Nishioka; Makoto Shibuya; Kuninori Ohtsuka; Yukio Ikeda; Jo Haraoka
Journal:  Neuroradiology       Date:  2010-03-18       Impact factor: 2.804

Review 5.  Xanthogranuloma of the sellar region of children: series of five cases and literature review.

Authors:  Yuuta Kamoshima; Yutaka Sawamura; Hiroaki Motegi; Kanako Kubota; Kiyohiro Houkin
Journal:  Neurol Med Chir (Tokyo)       Date:  2011       Impact factor: 1.742

6.  Parasellar xanthogranulomas.

Authors:  Redi Rahmani; Madhav Sukumaran; Angela M Donaldson; Olga Akselrod; Ehud Lavi; Theodore H Schwartz
Journal:  J Neurosurg       Date:  2015-01-23       Impact factor: 5.115

7.  [Histopathological study of the "cholesterol granuloma reaction" in the sellar and juxta-sellar tumors].

Authors:  K Shirataki; S Okada; S Matsumoto
Journal:  No To Shinkei       Date:  1988-02

Review 8.  Xanthomatous pituitary lesions: a report of two cases and review of the literature.

Authors:  Morton G Burt; Adrienne L Morey; Jenny J Turner; Malcolm Pell; John P Sheehy; Ken K Y Ho
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

9.  Xanthogranuloma in the suprasellar region.

Authors:  Sei Sugata; Hirofumi Hirano; Kazutaka Yatsushiro; Shunji Yunoue; Katsumi Nakamura; Kazunori Arita
Journal:  Neurol Med Chir (Tokyo)       Date:  2009-03       Impact factor: 1.742

10.  Xanthogranulomatous hypophysitis: a rare and often mistaken pituitary lesion.

Authors:  Jaya Sujatha Gopal-Kothandapani; Veejay Bagga; Stephen B Wharton; Daniel J Connolly; Saurabh Sinha; Paul J Dimitri
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-01-01
View more
  4 in total

1.  Collision sellar lesions: coexistence of pituitary adenoma and Rathke cleft cyst-a single-center experience.

Authors:  Annelise de Almeida Verdolin; Elisa Baranski Lamback; Nina Ventura; André Guasti; Paulo José da Mata Pereira; Mônica R Gadelha; Leila Chimelli
Journal:  Endocrine       Date:  2019-12-04       Impact factor: 3.633

2.  FROM DIABETES INSIPIDUS TO SELLAR XANTHOGRANULOMA - A "YELLOW BRICK ROAD" DEMANDING TEAM-WORK.

Authors:  M Stojanovic; E Manojlovic-Gacic; S Pekic; T Milojevic; D Miljic; M Doknic; M Nikolic Djurovic; Z Jemuovic; M Petakov
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

Review 3.  Xanthogranuloma of the Sellar Region: A Comprehensive Review of Neuroimaging in a Rare Inflammatory Entity.

Authors:  Vera Lozovanu; Carmen Emanuela Georgescu; Lavinia Maria Florescu; Carmen Georgiu; Horatiu Silaghi; Andrian Fratea; Cristina Alina Silaghi
Journal:  J Pers Med       Date:  2022-06-08

4.  Endoscopic transsphenoidal drainage of a petrous apex cholesterol granuloma using a frontal sinus nasal stent: a case report with long term follow up.

Authors:  Brandon Lucke-Wold; Cara Fleseriu; Haley Calcagno; Timothy Smith; Joshua Levy; Jeremy Ciporen
Journal:  Br J Neurosurg       Date:  2020-06-09       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.